Diabetes
Latest News
Body weight influences SGLT2-inhibitor effects in type 1 diabetes
BARCELONA – Patients with a high body mass index gain the most benefit from sodium-glucose cotransporter 2 inhibitors added to insulin.
Conference Coverage
Synchronizing refills saves money, improves outcomes
NATIONAL HARBOR, MD. – Synchronizing medication refills resulted in higher adherence, fewer hospitalizations, and lower health care costs in a...
Latest News
GABA falls short for type 1 diabetes prevention in children
BARCELONA – There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.
Conference Coverage
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
BARCELONA – Once-weekly treatment with subcutaneous semaglutide yielded greater reductions in HbA1c and body weight than once-daily...
Latest News
Severe hypoglycemia, poor glycemic control fuels fracture risk in older diabetic patients
The association between severe hypoglycemia, poor glycemic control, and fracture risk seems to be stronger in men than in postmenopausal women.
Latest News
Dapagliflozin approved for reducing HF hospitalization in diabetes
It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.
Conference Coverage
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.
From the Journals
Eating disorders may add to poor type 2 control, but BMI confounds the issue
From the Journals
Duloxetine ‘sprinkle’ launches for patients with difficulty swallowing
Conference Coverage
Obesity ups type 2 diabetes risk far more than lifestyle, genetics
BARCELONA –
Latest News
Closed-loop delivery system increases time in target glucose range
Patients with type 1 diabetes spent an additional 2.6 hr/day in the target range, compared with those using an insulin pump.